Drug profile · INN
adalimumab-afzb
ABRILADA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
adalimumab-afzb (ABRILADA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN adalimumab-afzb
Brand ABRILADA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is adalimumab-afzb?
adalimumab-afzb (ABRILADA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for adalimumab-afzb?
ABRILADA is a marketed brand name for adalimumab-afzb. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of adalimumab-afzb?
adalimumab-afzb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.